Based on the Canon of Medicine by Avicenna (980-1037), fever is defined as an abnormal heat ignited in the heart and spreads throughout the body via the arteries (1). Following the Galen theory about fevers (2), Avicenna describes three main types of fevers in relation with the three types of material structures in the body (2). According to the theory of "Natural bodily af-fairs" mentioned in ...

691 evaluation of non-adherence in chronic disease management and in patients with hypertension in particular. However, there is a paucity of data in the context of hypertensive patients’ perspective from developing countries, to gather in-depth information towards hypertension management. In the context of developing nations like Pakistan, health-seeking behaviour always occurs in the context ...

Based on the teachings of ancient philosopher/physicians in Greece, Persia and Islamic lands inflammation starts with a non-self hot dystemperament which can involve any type of corporeal structures of the body (tissues, primary and secondary fluids, subtle & fine bodies). Such Non-self  hot dystemperaments in neural tissues might happen due to the somatic and/or psychological causes, and ...

Al-Fatihah is one of the Quranic verses that have a special position. Consequently, it obligatory to recite every time they pray. Meanwhile practically, in jahar prayer, some congregations al-Fatihah, but however rejected. There an obligation listen imam reciting. This article examines hadiths reciting al-Fatihah for congregation prayer and its wisdom. research uses approach hadith studies Isla...

You have accessJournal of UrologyBladder Cancer: Basic Research & Pathophysiology I (PD37)1 Sep 2021PD37-01 LOSS OF FOXA1 RESULTS IN GENOME-WIDE EPIGENETIC REPROGRAMMING AND ACTIVATION INTERFERON-RESPONSE GENES INCLUDING CD274/PD-L1 Hironobu Yamashita, Wenhuo Hu, Joshua Warrick, Vonn Walter, Jenna Craig, Hikmat Al-Ahmadie, and David Degraff YamashitaHironobu Yamashita More articles by this auth...

The Mammary Prevention 3 (MAP.3) placebo-controlled randomized trial in 4,560 high-risk postmenopausal women showed a 65% reduction in invasive breast cancer with the use of exemestane at 35 months of median follow-up. Few differences in adverse events were observed between the arms, suggesting a promising risk:benefi t balance with exemestane for use in chemoprevention. Yet, the MAP.3 design a...